ArticleCritical care (London, England)2006
Corticosteroids influence the mortality and morbidity of acute critical illness.
Article in Critical care (London, England), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 47 citations in OpenAlex.
- Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.Critical care (London, England) · 2007Trial
- Article
- Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing CaFrontiers in pharmacology · 2023Article
- Zieve Syndrome in a Patient With Hepatitis C.Cureus · 2022Article
- Underrecognized Zieve's syndrome, A case report.Annals of medicine and surgery (2012) · 2021Article
- Glucocorticoids and the Brain after Critical Illness.Endocrinology · 2021Review
- Moving towards personalized treatments of immune-related adverse events.Nature reviews. Clinical oncology · 2020Review
- Zieve syndrome in acute alcoholic hepatitis.Proceedings (Baylor University. Medical Center) · 2020Article
- Zieve's Syndrome Presenting With Severe Hypertriglyceridemia.ACG case reports journal · 2019Article
- Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic control.Annals of intensive care · 2015Article
- Toxoplasma gondii infection in the peritoneal macrophages of rats treated with glucocorticoids.Parasitology research · 2014Article
- Corticosteroid therapy in acute respiratory distress syndrome.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2013Review
- Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry.Critical care (London, England) · 2010Article
- Corticosteroids and erythropoeitin-receptor agonists.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2008Article
- Zieve Syndrome Beyond Alcohol: A Case and Literature Review Highlighting Autoimmune and Nutritional Contributions to a Rare Hemolytic Triad.Journal of investigative medicine high impact case reportsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUse of corticosteroids for adrenal supplementation and attenuation of the inflammatory and immune response is widespread in acute critical illness. The study hypothesis was that exposure to corticosteroids influences the mortality and morbidity in acute critical illness.
methodsThis case-control retrospective study was performed in a single multidisciplinary intensive care unit at a tertiary care institution and consisted of 10,285 critically ill patients admitted between 1 January 1999 and 31 December 2004. Demographics, comorbidities, acute illness characteristics including severity measured by Sequential Organ Failure Assessment, concurrent medications, therapeutic interventions and incidence of infections were obtained from electronic medical records, were examined with multiple regression analysis and were adjusted for propensity of corticosteroid exposure. The primary outcome was hospital death, and the secondary outcome was transfer to a care facility at hospital discharge.
resultsCorticosteroid exposure in 2,632 (26%) patients was characterized by younger age, more females, higher Charlson comorbidity and maximal daily Sequential Organ Failure Assessment scores compared with control patients. Corticosteroids potentiated metabolic and neuromuscular sequels of critical illness with increased requirements for diuretics, insulin, protracted weaning from mechanical ventilation, need for tracheostomy and discharge to a care facility. Early exposure to corticosteroids predisposed to recurrent and late onset of polymicrobial and fungal hospital-acquired infections. Corticosteroids increased the risk for death or disability after adjustments for comorbidities and acute illness characteristics.
conclusionCorticosteroids increased the risk for death or disability in critical illness. Hospital-acquired infections and metabolic and neuromuscular sequels of critical illness were exacerbated by corticosteroids. Careful appraisal of the indications for use of corticosteroids is necessary to balance the benefits and risks from exposure in acute critical illness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.